Profile
Hans P.
Schmid has served as Managing Director for SciClone Pharmaceuticals International Ltd.
since July 2004.
He previously served as Vice President, Finance, Administration and Business Development since joining SciClone in May 2001.
He has over 25 years of financial and pharmaceutical experience in the U.S.
and international markets.
Prior to joining SciClone, Mr. Schmid was Chief Financial Officer from December 1999 to April 2001 for Questcor Pharmaceuticals, Inc. and Senior Vice President, International Business Development from February 1997 to September 1999 for Oread, Inc., a contract pharmaceutical company.
From 1985 to 1997 he worked at Syntex Corporation as Vice President of Finance and Administration for Pharmaceutical Operations Asia/Pacific region and at F.
Hoffmann-LaRoche as Senior Vice President, Finance and Head of Administrative Services for Roche Bioscience.
Previously he held financial and operational positions with Itel Corporation in Germany, Japan, England and the United States.
He received his B.A.
degree from the Commercial Trade School, Lucerne, Switzerland, and has studied International Business Management and Finance at San Francisco State University.
Former positions of Hans P. Schmid
Companies | Position | End |
---|---|---|
SCICLONE PHARMACEUTICALS, INC. | Chief Administrative Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
SciClone Pharmaceuticals LLC
SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
- Stock Market
- Insiders
- Hans P. Schmid